Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology
Reference79 articles.
1. American Psychiatric Association. Practice Guidelines for the treatment of major depressive disorder. 2010. http://psychiatryonline.org/content.aspx?bookid=28§ionid=1667485 . Accessed 19 June 2014.
2. Richelson E. Multi-modality: a new approach for the treatment of major depressive disorder. Int J Neuropsychopharmacol. 2013;16(6):1433–42.
3. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28–40.
4. Lundbeck. Brintellix™ (vortioxetine hydrobromide tablets): US prescribing information. 2013. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204447s000lbl.pdf . Accessed 20 June 2014.
5. Lundbeck. Brintellix™ (vortioxetine tablets): EU summary of product characteristics. 2014. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002717/WC500159449.pdf . Accessed 20 June 2014.
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献